Prot# H3E-MC-JMHD(a): Randomized, Open-Label, Phase 3 Study of Pemetrexed plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab versus Paclitaxel plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patient

Project: Research project

Project Details

StatusFinished
Effective start/end date6/17/09 → 7/30/17

Funding

  • Lilly Research Laboratories (H3E-MC-JMHD(a))